We hypothesized that having higher level of SDF-1 may be associated with an increased risk of recurrent stroke and cardiovascular events after ischemic stroke and the effect of SDF-1 on ischemic stroke prognosis may be different in patients with and without diabetes mellitus. This evidence concerns the gene CXCL12 and stroke disorder.